Clinical Trial Update: Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating early and whole-course nutritional support with Nutren Optimum during IMRT for nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nutren Optimum

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Nutritional Support | Phase 2, Phase 3 | Status: UNKNOWN